Consolidated Capital Management LLC Raises Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Consolidated Capital Management LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 43.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,133 shares of the healthcare conglomerate's stock after purchasing an additional 2,165 shares during the quarter. UnitedHealth Group makes up 2.0% of Consolidated Capital Management LLC's holdings, making the stock its 18th largest position. Consolidated Capital Management LLC's holdings in UnitedHealth Group were worth $3,755,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently made changes to their positions in the company. Richelieu Gestion SA purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth $26,000. CGC Financial Services LLC raised its stake in UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after buying an additional 50 shares during the last quarter. NewSquare Capital LLC raised its stake in UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate's stock valued at $33,000 after buying an additional 51 shares during the last quarter. LFA Lugano Financial Advisors SA raised its stake in UnitedHealth Group by 148.1% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate's stock valued at $35,000 after buying an additional 40 shares during the last quarter. Finally, Annapolis Financial Services LLC raised its stake in UnitedHealth Group by 38.6% in the third quarter. Annapolis Financial Services LLC now owns 79 shares of the healthcare conglomerate's stock valued at $40,000 after buying an additional 22 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

Shares of NYSE UNH traded up $5.78 during midday trading on Friday, hitting $512.81. The stock had a trading volume of 2,784,585 shares, compared to its average volume of 4,608,288. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70. The company has a market capitalization of $471.83 billion, a PE ratio of 31.35, a P/E/G ratio of 1.49 and a beta of 0.55. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The stock has a 50 day simple moving average of $482.28 and a 200-day simple moving average of $511.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping analysts' consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. During the same quarter last year, the business posted $6.26 earnings per share. The firm's revenue was up 8.6% compared to the same quarter last year. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a yield of 1.47%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group's dividend payout ratio (DPR) is 45.97%.

Insiders Place Their Bets

In other news, EVP Erin Mcsweeney sold 1,236 shares of the business's stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares of the company's stock, valued at approximately $4,527,306.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the company's stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares of the company's stock, valued at approximately $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of the business's stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on UNH shares. Royal Bank of Canada decreased their price target on UnitedHealth Group from $596.00 to $555.00 and set an "outperform" rating for the company in a research note on Wednesday, April 17th. HSBC raised UnitedHealth Group from a "reduce" rating to a "hold" rating and set a $460.00 price objective on the stock in a report on Thursday, April 4th. Stephens reissued an "overweight" rating and issued a $605.00 price objective on shares of UnitedHealth Group in a report on Thursday, February 8th. Oppenheimer reissued an "outperform" rating and issued a $610.00 price objective on shares of UnitedHealth Group in a report on Wednesday, January 17th. Finally, Truist Financial reaffirmed a "buy" rating and set a $600.00 target price on shares of UnitedHealth Group in a report on Wednesday, April 17th. Four analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of "Moderate Buy" and an average price target of $570.05.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.